Safety
Side effects, contraindications, sourcing risk, and practical safety guidance.
15 articlesCommon Side Effects of GLP-1 Peptides: Semaglutide and Tirzepatide
The documented common and serious side effects of semaglutide and tirzepatide, based on their FDA-approved labeling.
Read the guide → 🛡 SafetyContraindications for GLP-1 Medications: Who Should Avoid Them
Who should avoid GLP-1 medications like semaglutide and tirzepatide, based on their FDA-approved contraindications.
Read the guide → 🛡 SafetyCounterfeit Peptides: How to Recognize the Warning Signs
How to recognize warning signs of counterfeit peptide products, including fake versions of FDA-approved GLP-1 drugs.
Read the guide → 🛡 SafetyDrug Interactions to Know Before Starting a GLP-1 Peptide
Documented drug interactions with GLP-1 medications like semaglutide and tirzepatide, and why they matter.
Read the guide → 🛡 SafetyGrowth Hormone Secretagogues and Blood Sugar: What to Monitor
Why growth hormone secretagogue peptides can affect blood sugar and insulin sensitivity, and what to monitor.
Read the guide → 🛡 SafetyHow to Talk to Your Doctor About Peptide Therapy
Practical guidance on how to have an honest, productive conversation with your doctor about peptide use, including unapproved peptides.
Read the guide → 🛡 SafetyInjection Site Safety: Reducing Risk With Any Self-Administered Peptide
Practical injection site safety practices for anyone self-administering an injectable peptide, regardless of which compound.
Read the guide → 🛡 SafetyPeptide Cycling and Tolerance: What the Safety Literature Says
What is actually known about peptide cycling and tolerance, and how much of common cycling advice is evidence-based versus anecdotal.
Read the guide → 🛡 SafetyPeptides and Pregnancy: Why the Research Says Avoid
Why GLP-1 and most other peptides are not recommended during pregnancy, based on current research and labeling guidance.
Read the guide → 🛡 SafetySigns of an Allergic Reaction to Injectable Peptides
How to recognize the signs of a mild versus a serious allergic reaction to an injectable peptide, and when to seek emergency care.
Read the guide → 🛡 SafetyThyroid and Pancreatic Risk Warnings for GLP-1 Medications
A closer look at the specific thyroid and pancreatic risk warnings on GLP-1 drug labels, and what the underlying evidence shows.
Read the guide → 🛡 SafetyWhat We Don't Know: Long-Term Safety Data Gaps for Popular Peptides
An honest look at what long-term safety data does and doesn't exist for popular peptides, including newer FDA-approved drugs.
Read the guide → 🛡 SafetyWhen to Stop a Peptide and Seek Medical Care
Concrete warning signs that should prompt stopping a peptide and seeking medical evaluation, across compound categories.
Read the guide → 🛡 SafetyWhy "Natural" or "Research Grade" Labels Don't Guarantee Safety
Why marketing terms like natural and research-grade don't correspond to any regulated safety or quality standard.
Read the guide → 🛡 SafetyWhy Sourcing Matters: Contamination and Purity Risks in Unregulated Peptides
Documented contamination and purity issues found in unregulated peptide products, and why sourcing is a distinct risk from the compound itself.
Read the guide →